| Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up PG Casali, N Abecassis, S Bauer, R Biagini, S Bielack, S Bonvalot, ... Annals of Oncology 29, iv51-iv67, 2018 | 988 | 2018 |
| Gastrointestinal stromal tumours: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up PG Casali, N Abecassis, S Bauer, R Biagini, S Bielack, S Bonvalot, ... Annals of Oncology 29, iv68-iv78, 2018 | 947* | 2018 |
| Soft tissue and visceral sarcomas: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up☆ A Gronchi, AB Miah, AP Dei Tos, N Abecassis, J Bajpai, S Bauer, ... Annals of Oncology 32 (11), 1348-1365, 2021 | 582 | 2021 |
| Bone sarcomas: ESMO–PaedCan–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up PG Casali, S Bielack, N Abecassis, HT Aro, S Bauer, R Biagini, ... Annals of Oncology 29, iv79-iv95, 2018 | 547 | 2018 |
| Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label … NM Marina, S Smeland, SS Bielack, M Bernstein, G Jovic, MD Krailo, ... The Lancet Oncology 17 (10), 1396-1408, 2016 | 508 | 2016 |
| Gastrointestinal stromal tumours: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up PG Casali, JY Blay, N Abecassis, J Bajpai, S Bauer, R Biagini, S Bielack, ... Annals of oncology 33 (1), 20-33, 2022 | 324 | 2022 |
| Bone sarcomas: ESMO–EURACAN–GENTURIS–ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up SJ Strauss, AM Frezza, N Abecassis, J Bajpai, S Bauer, R Biagini, ... Annals of Oncology 32 (12), 1520-1536, 2021 | 232 | 2021 |
| Pazopanib in advanced vascular sarcomas: an EORTC Soft Tissue and Bone Sarcoma Group (STBSG) retrospective analysis A Kollár, RL Jones, S Stacchiotti, H Gelderblom, M Guida, G Grignani, ... Acta oncologica 56 (1), 88-92, 2017 | 181 | 2017 |
| Deterministic rather than stochastic factors explain most of the variation in the expression of skin telangiectasia after radiotherapy A Safwat, SM Bentzen, I Turesson, JH Hendry International Journal of Radiation Oncology* Biology* Physics 52 (1), 198-204, 2002 | 167 | 2002 |
| The immunobiology of low-dose total-body irradiation: more questions than answers A Safwat Radiation research 153 (5), 599-604, 2000 | 138 | 2000 |
| Diagnosis and management of tropomyosin receptor kinase (TRK) fusion sarcomas: expert recommendations from the World Sarcoma Network GD Demetri, CR Antonescu, B Bjerkehagen, JVMG Bovee, K Boye, ... Annals of Oncology 31 (11), 1506-1517, 2020 | 128 | 2020 |
| Corrections to PG Casali, N Abecassis, HT Aro, S Bauer, R Biagini, S Bielack, ... Ann Oncol 29, iv267, 2018 | 113 | 2018 |
| Adipose mesenchymal stem cells–derived exosomes attenuate retina degeneration of streptozotocin-induced diabetes in rabbits A Safwat, D Sabry, A Ragiae, E Amer, RH Mahmoud, RM Shamardan Journal of circulating biomarkers 7, 1849454418807827, 2018 | 112 | 2018 |
| Epithelioid hemangioendothelioma, an ultra-rare cancer: a consensus paper from the community of experts S Stacchiotti, AB Miah, AM Frezza, C Messiou, C Morosi, A Caraceni, ... ESMO open 6 (3), 100170, 2021 | 106 | 2021 |
| Palmar-plantar erythrodysesthesia associated with chemotherapy and its treatment KP Farr, A Safwat Case reports in oncology 4 (1), 229-235, 2011 | 98 | 2011 |
| Prognostic factors for local recurrence and mortality in adult soft tissue sarcoma of the extremities and trunk wall: a cohort study of 922 consecutive patients K Maretty-Nielsen, N Aggerholm-Pedersen, A Safwat, PH Jørgensen, ... Acta orthopaedica 85 (3), 323-332, 2014 | 96 | 2014 |
| The role of low-dose total body irradiation in treatment of non-Hodgkin's lymphoma: a new look at an old method A Safwat Radiotherapy and Oncology 56 (1), 1-8, 2000 | 96 | 2000 |
| Cancer stem cell overexpression of nicotinamide N-methyltransferase enhances cellular radiation resistance FP D’Andrea, A Safwat, M Kassem, L Gautier, J Overgaard, MR Horsman Radiotherapy and Oncology 99 (3), 373-378, 2011 | 83 | 2011 |
| Low‐Grade Fibromyxoid Sarcoma: Incidence, Treatment Strategy of Metastases, and Clinical Significance of the FUS Gene K Maretty-Nielsen, S Baerentzen, J Keller, HB Dyrop, A Safwat Sarcoma 2013 (1), 256280, 2013 | 79 | 2013 |
| Pazopanib in metastatic osteosarcoma: significant clinical response in three consecutive patients A Safwat, A Boysen, A Lücke, P Rossen Acta Oncologica 53 (10), 1451-1454, 2014 | 51 | 2014 |
